04/22/2022 | Press release | Archived content
Palisade Bio, Inc.
5800 Armada Drive, Suite 210
Carlsbad, California 92008
April 22, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: |
Michael Davis |
Laura Crotty
Re: |
Palisade Bio, Inc. (the "Company") |
Registration Statement on Form S-3
Filed: March 18, 2022
File No. 333-263705
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-3, to become effective at 4:00 p.m. Eastern Time on April 26, 2022 or as soon thereafter as is practicable.
If you have any questions regarding this request, please contact Karen E. Deschaine of Cooley LLP at (858) 550-6088.
Very truly yours,
PALISADE BIO, INC.
/s/ Thomas M. Hallam, Ph.D. |
Thomas M. Hallam, Ph.D. |
Chief Executive Officer |